These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 16376825)

  • 1. Novel and emerging therapies for asthma.
    Leath TM; Singla M; Peters SP
    Drug Discov Today; 2005 Dec; 10(23-24):1647-55. PubMed ID: 16376825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of CpG oligonucleotides in treatment of asthma and allergic disease.
    Fonseca DE; Kline JN
    Adv Drug Deliv Rev; 2009 Mar; 61(3):256-62. PubMed ID: 19167442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunomodulation therapy for allergic asthma. What is already possible, what is to come?].
    Taube C; Buhl R
    Dtsch Med Wochenschr; 2008 Apr; 133(14):727-32. PubMed ID: 18363195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agents against cytokine synthesis or receptors.
    Yamagata T; Ichinose M
    Eur J Pharmacol; 2006 Mar; 533(1-3):289-301. PubMed ID: 16457805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug therapy in asthma bronchiale in the new millennium.
    Szelenyi I; Pahl A
    Pharmazie; 2002 Feb; 57(2):83-6. PubMed ID: 11878194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CpG oligodeoxynucleotides in asthma.
    Hussain I; Kline JN
    Curr Opin Investig Drugs; 2001 Jul; 2(7):914-8. PubMed ID: 11757790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The future of asthma therapy].
    Solèr M
    Schweiz Med Wochenschr; 2000 Feb; 130(8):277-81. PubMed ID: 10726286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asthma.
    Fanta CH
    N Engl J Med; 2009 Mar; 360(10):1002-14. PubMed ID: 19264689
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-IgE and other antibody targets in asthma.
    Singh J; Kraft M
    Handb Exp Pharmacol; 2008; (181):257-88. PubMed ID: 18071950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of monoclonal anti-IgE antibodies (rhu-MAb) in the treatment of allergic bronchial asthma].
    Targowski T; From S
    Pol Merkur Lekarski; 2003 Jan; 14(79):65-8. PubMed ID: 12712834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic targets for persistent airway inflammation in refractory asthma.
    Murphy P; Hillman T; Rajakulasingam K
    Biomed Pharmacother; 2010 Feb; 64(2):140-5. PubMed ID: 20074901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Future perspectives in the therapy of asthma in children].
    Tosca MA; Villa E; Rossi GA
    Minerva Pediatr; 2008 Apr; 60(2):235-47. PubMed ID: 18449140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pneumology. Anti-IgE antibodies in the treatment of asthma].
    Leuenberger P; Sauty A; Rochat T
    Rev Med Suisse; 2007 Jan; 3(93):56-9. PubMed ID: 17354662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulin E-mediated airway inflammation is active in most patients with asthma.
    Hayden ML
    J Am Acad Nurse Pract; 2007 Sep; 19(9):439-49. PubMed ID: 17760568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulation as asthma therapy: where do we stand?
    Barnes PJ
    Eur Respir J Suppl; 1996 Aug; 22():154s-159s. PubMed ID: 8871062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pratical aspects of anti-Ige therapy in severe allergic asthma].
    Taramarcaz P; Hauser C; Rochat T
    Rev Med Suisse; 2007 Apr; 3(108):1050-2, 1054-5. PubMed ID: 17552257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Omalizumab, an anti-IgE monoclonal antibody to treat severe asthma].
    Michils A; Sternon J
    J Pharm Belg; 2006; 61(3):83-7. PubMed ID: 17058881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin E: role in asthma and allergic disease: lessons from the clinic.
    Owen CE
    Pharmacol Ther; 2007 Jan; 113(1):121-33. PubMed ID: 17000005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of anti-IgE monoclonal antibody (omalizumab) in the treatment of bronchial asthma and allergic respiratory diseases.
    D'Amato G
    Eur J Pharmacol; 2006 Mar; 533(1-3):302-7. PubMed ID: 16464445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targets for asthma therapy.
    Boushey H
    Allerg Immunol (Paris); 2000 Nov; 32(9):336-41. PubMed ID: 11195856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.